USPTO serial 76472327
THE DIFFERENCE IS INSIDE
Reviewed by CopyMark Law Group
- Filing date
- Status date
- Registration date
- Mar 21, 2006
- Examiner
- EDWARDS, ALICIA COLLINS
- Law office
- PUBLICATION AND ISSUE SECTION
What this means
Status 710 means the registration was cancelled because a required Section 8 declaration of continued use was not filed within the deadline (including any grace period). The federal registration is no longer active. Evaluate filing a new application if you still use the mark, or petition if cancellation was erroneous. Consult counsel on remaining common-law rights.
Need help with THE DIFFERENCE IS INSIDE?
If you own this trademark, we can monitor new filings and help with USPTO deadlines. If you do not, we can file a new U.S. application.
Owner
D-85354 Freising, DE
D-85354 FREISING, DE
D-85354 FREISING, DE
D-85354 FREISING, DE
DEGUSSA FRESHTECH BEVERAGES LLC
MILWAUKEE, WI
Attorney of record
The USPTO lists this attorney as the applicant's representative for correspondence on this application.
Leon Medzhibovsky
LEON MEDZHIBOVSKY FULBRIGHT & JAWORSKI LLP666 FIFTH AVENEW YORK, NY 10103UNITED STATESGoods and services
| Class | Description | Status | First use |
|---|---|---|---|
| 001 | Diagnostic chemical preparations for scientific use; chemical preparations, namely, phospholipids, amino acids, fatty acids, oils, probiotics, prebiotics, aromatics and fragrances, hydrocolloids used in the research, science, pharmaceutical, dietary and food supplement, biotechnological, veterinary, medical, agricultural and scientific industries; diagnostic chemical preparations for use by research laboratories; enzymatically hydrolyzed collagen for use in the manufacture of preparations for body, health care products, pharmaceuticals, veterinary substances and dietetic preparations for non-medical use; reagents and chemical compounds used for scientific and research purposes, and for scientific and research purposes in the production and synthesis of oligonucleotides, nucleoside and nucleotide derivatives used for the synthesis of nucleic acids; enzymes for scientific and research purposes; culture media for scientific and research purposes; emulsifiers for scientific and research purposes; fermentation extracts for a wide variety of fields; fermentation extracts, namely, carotenoids and enzymes used for manufacture of a wide variety of medical and veterinary products | SECTION 8 - CANCELLED | — |
| 005 | Pharmaceutical, veterinary and health care preparations for use in the treatment of a wide variety of diseases and medical conditions, namely, disorders of the gastrointestinal tract, urinary dysfunction, disorders of the reproductional system, atherosclerosis, hypertension, prostate, heart disease, lipid deficiencies, nervous and muscle system and the brain, treatment of vitamins, amino acids, carbohydrate and trace elements deficiencies, treatment of blood glucose levels, controlling blood cholesterol, promote liver health, regeneration and repair of cell membranes, repair of damaged cells, promoting cell function, promotion of liver detoxification and health, promoting recovery and function of the liver, promoting hematic health and function, promoting health and function of the brain and cognitive ability, and to enhance athletic performance; pharmaceutical, veterinary and health care preparations, namely, phospholipids, collagen, creatine, pyruvicacid and aipha-lipoic acid and their salt derivatives and precursor for use in the treatment of a wide variety of diseases, namely, disorders of the gastrointestinal tract, urinary dysfunction, disorders of the reproduction system, atherosclerosis, hypertension, prostate, heart disease, lipid deficiencies affecting the function of the eyes, nervous and muscle system and the brain, treatment of vitamins, amino acids, carbohydrate and trace elements deficiencies, treatment of blood glucose levels, controlling blood cholesterol, promote liver health, regeneration and repair of cell membranes, repair of damaged cells, promoting cell function, promotion of liver detoxification and health, promoting recovery and function of the liver, promoting hematic health and function, promoting health and function of the brain and cognitive ability, and to enhance athletic performance; dietetic nutrients for use as dietary and nutritional supplements for enhancing endurance and performance in sports used by sportsmen and athletes for enhancing athletic performance; dietetic nutrients for use as dietary and nutritional supplements containing fish oil for medical use, namely, foods for medically restricted diets, dietary and nutritional supplements, and fish oil based nutritional supplements used for prophylaxis of arthrosis, namely, nutrients based on enzymatically changed collagens and serum cholesterol decreasing ingredients, including those of vegetable origin; natural extracts and concentrated active ingredients sold as an integral component of dietary supplements; dietary products for medical use, namely, dietary supplements and nutraceuticals for use as dietary supplements; baby food and baby food containing unsaturated fatty acids for clinical and preferably enteral and parenteral nutrition; dietary supplements and nutraceuticals for use as dietary and nutritional supplements for use in the treatment of a wide variety of diseases and medical conditions; dietary supplements and nutraceuticals for use as dietary and nutritional supplements based on or containing unsaturated fatty acids, phospholipids, creatine, pyruvate and alpha-lipoic acid derivatives and precursors; diagnostic chemical preparations for use by medical laboratories; natural extracts and concentrated active ingredients, namely, herbal and botanical extracts, amino acids, fatty acids, oils, probiotics, prebiotics, phospholipids, emulsifiers, enzymes, aromatics and fragrances, hydrocolloids and texturizing compounds for use in the manufacture of dietary and nutritional supplements, and nutritionally-fortified foods and beverages | SECTION 8 - CANCELLED | — |
| 029 | Milk and milk products, namely, sour milk, cheese, yogurt, kefir, kumiss, and lactic acid; edible oils and fats, including phospholipids and preparations produced thereof | SECTION 8 - CANCELLED | — |
| 032 | Fruit beverages and fruit juices; non-alcoholic fruit extracts for use in the preparation of beverages; syrups and other preparations for preparing soft drinks, fruit juices and fruit drinks, including natural extracts and concentrated active ingredients for beverage fields | SECTION 8 - CANCELLED | — |
Related trademarks
CopyMark links this record to cited §2(d) serials, the owner's other marks, Nice classes, similar mark names, and recently changed USPTO applications.
- Other trademarks owned by Degussa BioActives GmbH
- Other trademarks owned by DEGUSSA FOOD INGREDIENTS GMBH
- Other trademarks owned by DEGUSSA FOOD INGREDIENTS GMBH
- Other trademarks owned by DEGUSSA FOOD INGREDIENTS GMBH
- Other trademarks owned by DEGUSSA FRESHTECH BEVERAGES LLC
- Other trademarks in Class 001
- Other trademarks in Class 005
- Other trademarks in Class 029
- Other trademarks in Class 032
- Similar marks named THE DIFFERENCE IS INSIDE
- Recently changed USPTO trademarks
- Recently filed trademarks
- Browse all trademark records
Prosecution history
| Date | Code | Event | What it means |
|---|---|---|---|
| Oct 26, 2012 | C8.. | CANCELLED SEC. 8 (6-YR) | — |
| Jul 12, 2006 | ASGN | AUTOMATIC UPDATE OF ASSIGNMENT OF OWNERSHIP | — |
| Mar 21, 2006 | R.PR | REGISTERED-PRINCIPAL REGISTER | Your trademark is registered on the Principal Register — the strongest form of federal trademark protection. You may use the ® symbol for the covered goods and services. Maintenance filings (Section 8 and renewals) are required to keep the registration alive. |
| Dec 27, 2005 | PUBO | PUBLISHED FOR OPPOSITION | Your mark was published in the USPTO Official Gazette for a 30-day opposition window. During that period, third parties who believe they would be harmed can file an opposition. If no opposition is filed, prosecution usually continues toward registration or a Notice of Allowance. |
| Dec 7, 2005 | NPUB | NOTICE OF PUBLICATION | — |
| Nov 7, 2005 | PREV | LAW OFFICE PUBLICATION REVIEW COMPLETED | — |
| Nov 4, 2005 | ALIE | ASSIGNED TO LIE | — |
| Nov 3, 2005 | CNEA | EXAMINERS AMENDMENT MAILED | — |
| Nov 3, 2005 | CNSA | APPROVED FOR PUB - PRINCIPAL REGISTER | — |
| Nov 3, 2005 | XAEC | EXAMINER'S AMENDMENT ENTERED | — |
| Nov 3, 2005 | CNEA | EXAMINERS AMENDMENT -WRITTEN | — |
| Feb 23, 2005 | CNRT | NON-FINAL ACTION MAILED | A non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application. |
| Feb 22, 2005 | CNRT | NON-FINAL ACTION WRITTEN | A non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application. |
| Dec 29, 2004 | ACEC | AMENDMENT FROM APPLICANT ENTERED | — |
| Nov 5, 2004 | CRFA | CORRESPONDENCE RECEIVED IN LAW OFFICE | — |
| Nov 5, 2004 | PAPER RECEIVED | — | |
| May 3, 2004 | CNFR | FINAL REFUSAL MAILED | A final Office Action (final refusal) means the examining attorney is maintaining at least one refusal and your options are narrower. You can file a response addressing the refusal, appeal to the Trademark Trial and Appeal Board, or let the application abandon. |
| Feb 5, 2004 | 1.BD | Sec. 1(B) CLAIM DELETED | — |
| Feb 5, 2004 | CRFA | CORRESPONDENCE RECEIVED IN LAW OFFICE | — |
| Feb 5, 2004 | PAPER RECEIVED | — | |
| Nov 3, 2003 | CFIT | CASE FILE IN TICRS | — |
| Sep 26, 2003 | CRFA | CORRESPONDENCE RECEIVED IN LAW OFFICE | — |
| Sep 26, 2003 | PAPER RECEIVED | — | |
| Mar 21, 2003 | CNRT | NON-FINAL ACTION MAILED | A non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application. |
| Mar 12, 2003 | DOCK | ASSIGNED TO EXAMINER | — |